Dev Labtech Ventures Approves 1:1 Bonus Issue, Doubling Share Capital

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Dev Labtech Ventures Approves 1:1 Bonus Issue, Doubling Share Capital
Overview

Dev Labtech Venture Ltd's Board of Directors has approved a 1:1 bonus equity share issue. The company will allot over 2.37 crore new shares, doubling its paid-up equity share capital from ₹11.86 crore to approximately ₹23.73 crore. The new shares will carry the same rights as existing ones.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Dev Labtech Ventures Board Approves 1:1 Bonus Share Issue

Dev Labtech Venture Ltd's board of directors has sanctioned a 1:1 bonus equity share issue, a move that will double the company's paid-up share capital. Following the approval, Dev Labtech will allot over 2.37 crore new shares.

The company's existing paid-up share capital stands at ₹11.86 crore. Post this bonus allotment, the capital is expected to increase to approximately ₹23.73 crore. The record date for determining eligible shareholders has been set for May 15, 2026, with the board approving the issue on May 18, 2026.

How Bonus Shares Work

A bonus issue is essentially a corporate action designed to reward shareholders by distributing additional shares for free. While this increases the number of shares held by an investor, the total value of their holding doesn't change immediately, as the market price per share typically adjusts downwards to reflect the increased supply.

This strategy can potentially enhance share liquidity and broaden the shareholder base. However, investors should note that a significant increase in outstanding shares can lead to a dilution of earnings per share (EPS) and other per-share metrics if the company's profits do not grow in proportion to the expanded share count.

Company Background

Dev Labtech Venture Ltd primarily operates in the manufacturing sector, focusing on precision-engineered components for industries such as automotive.

Changes for Shareholders

Shareholders participating in the bonus issue will see their total equity stake in Dev Labtech Venture Ltd automatically double. The total number of outstanding equity shares will rise to 4,74,52,556 after the allotment. The newly issued bonus shares will carry the same rights and privileges as existing equity shares.

Industry Peers

Within the precision-engineered components sector for automotive, Sansera Engineering Ltd serves as a comparable entity. Other companies operating in related manufacturing segments, though often with wider product ranges, include Dixon Technologies and Varroc Engineering.

Key Figures

  • Pre-bonus paid-up share capital: ₹11.86 Crore
  • Post-bonus paid-up share capital: ₹23.73 Crore
  • Bonus shares to be allotted: 2,37,26,278
  • Bonus ratio: 1:1

What to Monitor

Investors will likely monitor the credit of bonus shares into eligible shareholders' demat accounts. They will also observe the market's reaction to the increased share count and any potential short-term impact on per-share metrics. Tracking the company's future financial performance to see if profit growth keeps pace with the expanded share capital will be crucial.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.